Rising Prevalence of Chronic Diseases Among Pets
The rising prevalence of chronic diseases among pets, such as arthritis, anxiety, and inflammatory conditions, is significantly boosting the growth of the global veterinary cannabidiol (CBD) market. For instance, according to the Morris Animal Foundation, osteoarthritis is a common and increasingly recognized issue in pets, affecting an estimated 14 million adult dogs in the U.S. and 90% of cats over 12 years old showing X-ray evidence of the condition. Also, as per the VCA Animal Hospitals, around 25% of dogs of all ages experience painful osteoarthritis in one or more joints, with the condition becoming more common as dogs age. As dogs live longer, it is increasingly likely that every dog owner will encounter osteoarthritis at some stage.
Furthermore, Green Element, a CBD supply company, has released new research revealing a significant rise in pet anxiety in the U.S. over the past two years. Conducted in May 2022, the study surveyed 1,000 adults, including 650 dog owners and 350 cat owners. The findings show that dog separation anxiety increased by over 700%, while fear of strangers surged by 295%, becoming the leading cause of anxiety in dogs, surpassing fear of loud noises. Additionally, anxiety caused by other pets jumped from 16.5% in 2020 to 43.5% in 2022. Similarly, Invetx’s recent research study reveals that nearly 40% of dogs in the U.S. suffer from chronic osteoarthritis or pain, with both veterinarians and pet owners expressing interest in longer-acting therapeutics to reduce veterinary visits and ensure continuous treatment. The study, which surveyed 2,000 veterinarians and pet owners across the U.S. and Europe, found that veterinarians estimate over 40% of their canine patients show signs of osteoarthritis, much higher than previously reported. Additionally, 75% of pet owners are willing to pay a premium for treatments with longer intervals between doses, while 87% of veterinarians prefer therapies that require fewer visits. As demand for solutions that require fewer veterinary visits rises, the veterinary CBD market is positioned for continued growth, offering a promising alternative for managing these common ailments.
Increasing Use of Hemp Products, Both with and without CBD, in Animal Care
The increasing use of hemp products, both with and without cannabidiol (CBD), in animal care is significantly driving the growth of the global veterinary cannabidiol (CBD) market. As pet owners and veterinarians become more aware of the health benefits offered by hemp-based solutions, demand for these natural remedies is rising across the globe, leading to greater market expansion.
Diverse Health Benefits: Hemp products, both with and without CBD, are gaining popularity for their ability to address a wide range of health issues in animals, including pain relief, inflammation, anxiety, joint support, and digestive wellness. This versatility is broadening their adoption.
Natural and Safe Ingredients: Hemp products are derived from the hemp plant, making them appealing for pet owners looking for safe, non-toxic alternatives for their pets. Both CBD and non-CBD hemp-based solutions offer a plant-based approach to pet health.
Holistic Pet Wellness: The rising trend toward holistic and natural pet care has led many pet owners to incorporate hemp-based products into their pets' health routines, boosting demand for these products as a safer and effective solution.
Ease of Administration: Hemp-based products are available in various forms, such as oils, treats, capsules, and pellets, making it easy for pet owners to integrate them into their pets’ daily care routines, increasing convenience and accessibility.
Growing Veterinarian Endorsement: Veterinarians are becoming more supportive of hemp products due to their positive effects on pet health, driving greater adoption in clinical settings and expanding the market.
Awareness Through Education: Pet owners are gaining more knowledge about the benefits of hemp products through online resources, vet consultations, and social media, leading to a greater willingness to try these natural alternatives.
Sustainability and Ethical Sourcing: Hemp products are often seen as eco-friendly, appealing to pet owners who prioritize sustainability and responsible sourcing, which also contributes to their popularity.
The increasing use of hemp products—whether they contain CBD or not—is driving the growth of the global veterinary cannabidiol market. Pet owners, veterinarians, and online retailers are collectively fueling demand, leading to innovation, greater product availability, and wider market adoption of these natural solutions in animal care.
Increasing launch of veterinary cannabidiol (CBD) products
The increasing launch of veterinary cannabidiol (CBD) products, including both hemp products with CBD and hemp products without CBD, is significantly boosting the global veterinary cannabidiol market. Hemp products with CBD are gaining popularity for their therapeutic benefits, such as promoting relaxation, reducing pain, and alleviating inflammation in animals, which is driving demand in the pet care sector. At the same time, hemp products without CBD, such as hemp seed oil and hemp-based treats, are also gaining traction due to their nutritional value and overall health benefits such as promoting shiny coat, improving digestion, and enhancing joint health in animals. For instance,
February 2023: Pet Wellbeing launched "Chewies," its first line of vet-strength, herbal soft chews for dogs. These chewable supplements provide an easy and flavorful way to support dogs' health, offering all-natural, veterinarian-approved formulas. The new products add convenience for pet owners, complementing the brand's existing liquid tinctures and powders.
July 2021: VETCBD Hemp has launched its first equine-specific product, a 3000mg broad-spectrum CBD tincture derived from premium American-grown hemp. Designed for horses, the tincture supports brain function, joint mobility, and calmness, using triple-tested hemp and organic extra-virgin olive oil. The product is available for sale nationwide, except in Idaho, South Dakota, Nebraska, and California, where regulations prevent the sale of cannabinoid products for livestock.
February 2021: Canopy Animal Health, a division of Canopy Growth Corporation, has launched SurityPro, a new line of CBD products for dogs. The SurityPro range includes CBD soft chews and well drops, designed to support calm behavior, joint health, and overall well-being. Developed by leading scientists, these products offer a customized CBD dose for dogs of all sizes. SurityPro products also carry the National Animal Supplement Council (NASC) quality seal, ensuring high manufacturing and testing standards.
August 2020: ElleVet Sciences has introduced ElleVet Soft Gels, clinically-tested CBD + CBDA capsules for dogs, designed to support mobility, comfort, and calmness. Tasteless and scentless, these soft gels offer an easy way to administer relief to dogs, especially those sensitive to new smells. Developed with proprietary CBD + CBDA oil, proven effective in Cornell University trials, the soft gels are scientifically dosed for optimal results.
With a focus on scientific formulations and high-quality ingredients, these products are meeting the growing demand for natural, effective solutions in the pet care industry.
